Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients

European Journal of Ophthalmology

Volumn 18, Issue 1, 2008, Pages 94-98

  Dong, Q Y ^a,b   Cui, Y ^c   Chen, Li ^a   Song, J ^a   Sun, L ^a  

^a SHANDONG UNIVERSITY   (China)

^b LINYI PEOPLE'S HOSPITAL   (China)

^c Jinan Shierming Eye Hospital   (China)

Author keywords

8 hydroxy 2 deoxyguanosine (8 OHdG); Diabetic retinopathy

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; HEMOGLOBIN A1C; LIPID;

ADULT; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IN VIVO STUDY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URINE LEVEL;

EID: 41149171922     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800116     Document Type: Article

References (18)

1. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-4.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
3. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
4. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd ed. Oxford: Oxford University Press; 1999: OX2 6DP.
5. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2 -deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990; 87: 4533-7.
6. Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91: 327-9.
7. Cooke MS, Evans MD, Burd RM, et al. Induction and excretion of ultraviolet-induced 8-oxo-2 -deoxyguanosine and thymine dinners in vivo: implications for PUVA. J Invest Dermatol 2001; 116: 281-5.
8. Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta 2003; 334: 87-94.
9. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
10. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 1998; 31: 1047-60.
11. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007; 2007: 43603.
12. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49: 91-102.
13. Omata N, Tsukahara H, lto S, et al. Increased oxidative stress in childhood atopic dermatitis. Life Sci 2001; 69: 223-8.
14. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-5.
15. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med 1998; 25: 369-72.
16. Augustin AJ, Dick HB, Koch F, Schmidt-Erfurth U. Correlation of blood-glucose control with oxidative metabolites in plasma and vitreous body of diabetic patients. Eur J Ophthalmol 2002; 12: 94-101.
17. Yokoi M, Yamagishi SI, Takeuchi M, et al. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br J Ophthalmol 2005; 89: 673-5.
18. Harris Ml, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-9.